Sponsor Deadline
Posted: 6/13/2024

National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional)

Through this Funding Opportunity Announcement (FOA), the National Cancer Institute (NCI) invites applications for investigator-initiated Program Project (P01) applications. The proposed Program may address any of the broad areas of cancer research, including (but not limited to) cancer biology, cancer prevention, cancer diagnosis, cancer treatment, and cancer control. Basic, translational, clinical, and/or population-based studies in all of these research areas are appropriate. Each application submitted in response to this FOA must consist of at least three research projects and an Administrative Core. The projects must share a common central theme, focus, and/or overall objective.    


  • Letter of Intent Due Date(s): 30 days prior to the application due date
  • P Series Deadlines: Jan. 25, May 25, Sep. 25
  • AIDS Deadlines: Jan. 7, May 7, Sep. 7

PAR-23-059 Expiration Date May 08, 2026

Eligibility Requirements

The NCI encourages P01 applicants to take advantage of the multiple PD/PI option. The use of this option allows, for example, the designation of any (or all) of the leaders of the individual projects or cores as a PD/PI of the overall application.